Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmacogenomics (London)

• Publication date

  2013-09-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/pgs.13.147PMID 24024900PMCID PMC3888096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL[S]

  2013cited by this paper
• Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression.

  2013cited by this paper
• Hormonal and Chemical Regulation of Paraoxonases in Mice

  2012cited by this paper
• Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer.

  2012cited by this paper
• Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis.

  2012cited by this paper
• Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  2012cited by this paper
• Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: a HuGE review and meta-analysis.

  2012cited by this paper
• Dietary cholesterol increases paraoxonase 1 enzyme activity

  2012cited by this paper
• Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies

  2012cited by this paper
• Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity

  2012cited by this paper
• Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis

  2012cited by this paper
• Solubilization and Humanization of Paraoxonase-1

  2012cited by this paper
• Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease

  2012cited by this paper
• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma

  2011cited by this paper
• Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells.

  2011cited by this paper
• Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

  2011cited by this paper
• Paraoxonase-1 and clopidogrel efficacy

  2011cited by this paper
• Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis

  2011cited by this paper
• Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.

  2011cited by this paper
• Paraoxonase-1 and clopidogrel efficacy

  2011cited by this paper
• HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress.

  2011cited by this paper
• Paraoxonase-1 is a major determinant of clopidogrel efficacy

  2011cited by this paper
• Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

  2011cited by this paper
• Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.

  2011cited by this paper
• Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q10 and other oxidative stress markers in healthy volunteers.

  2010cited by this paper
• Human PON1, a biomarker of risk of disease and exposure.

  2010cited by this paper
• Purification of PON1 from Human Serum and Assessment of Enzyme Kinetics Against Metal Toxicity

  2010cited by this paper
• Quercetin up-regulates paraoxonase 1 gene expression via sterol regulatory element binding protein 2 that translocates from the endoplasmic reticulum to the nucleus where it specifically interacts with sterol responsive element-like sequence in paraoxonase 1 promoter in HuH7 liver cells.

  2010cited by this paper
• Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.

  2010cited by this paper
• Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice.

  2010cited by this paper
• The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.

  2010cited by this paper
• Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity

  2010cited by this paper
• Hepatic effects of rosiglitazone in rats with the metabolic syndrome.

  2010cited by this paper
• Effect of quercetin on paraoxonase 1 activity--studies in cultured cells, mice and humans.

  2010cited by this paper
• Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway.

  2010cited by this paper
• Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice.

  2010cited by this paper
• Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression.

  2010cited by this paper
• Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.

  2009cited by this paper
• Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.

  2009cited by this paper
• araoxonase 1 ( PON 1 ) expression in hepatocytes is upregulated by pomegranate olyphenols : A role for PPAR-pathway

  2009cited by this paper
• Paraoxonase 1 (PON1) status and substrate hydrolysis.

  2009cited by this paper
• Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.

  2009cited by this paper
• Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals

  2009cited by this paper
• Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.

  2009cited by this paper
• Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1).

  2009cited by this paper
• Serum paraoxonase‐I activity is unaffected by short‐term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus

  2009cited by this paper
• Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.

  2009cited by this paper
• The paraoxonases: role in human diseases and methodological difficulties in measurement

  2009cited by this paper
• Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning

  2008cited by this paper
• The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.

  2008cited by this paper
• The Functional Consequences of Polymorphisms in the Human PON1 Gene

  2008cited by this paper
• Comprar The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism | Mackness, Bharti | 9781402065606 | Springer

  2008cited by this paper
• Paraoxonases: An Historical Perspective

  2008cited by this paper
• Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues.

  2008cited by this paper
• The paraoxonases: their role in disease development and xenobiotic metabolism

  2008cited by this paper
• High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.

  2008cited by this paper
• Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin** This study was supported by National Institutes of Health Grants RO1 HL-56353 and RO1 HL-069038. Published, JLR Papers in Press, June 2, 2008.

  2008cited by this paper
• Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate Substrates

  2008cited by this paper
• Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.

  2008cited by this paper
• The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase.

  2007cited by this paper
• Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin

  2007cited by this paper
• Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia.

  2007cited by this paper
• Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease.

  2007cited by this paper
• Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.

  2007cited by this paper
• ADMINISTRATION OF EXOGENOUS ERYTHROPOIETIN β AFFECTS LIPID PEROXIDATION AND SERUM PARAOXONASE‐1 ACTIVITY AND CONCENTRATION IN PREDIALYSIS PATIENTS WITH CHRONIC RENAL DISEASE AND ANAEMIA

  2007cited by this paper
• ROSIGLITAZONE MODULATES FASTING AND POST‐PRANDIAL PARAOXONASE 1 ACTIVITY IN TYPE 2 DIABETIC PATIENTS

  2006cited by this paper
• Lead Exposure Is Associated with Decreased Serum Paraoxonase 1 (PON1) Activity and Genotypes

  2006cited by this paper
• Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits

  2006cited by this paper
• Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.

  2006cited by this paper
• Effects of Intranasal Estradiol Treatment on Serum Paraoxonase and Lipids in Healthy, Postmenopausal Women

  2006cited by this paper
• Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.

  2005cited by this paper
• Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.

  2005cited by this paper
• Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M

  2005cited by this paper
• Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing.

  2005cited by this paper
• Determinants of variation in serum paraoxonase enzyme activity in baboons Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400473-JLR200

  2005cited by this paper
• Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism

  2005cited by this paper
• Antioxidant effect of atorvastatin is independent of PON1 gene T(–107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients

  2005cited by this paper
• Induction of the Paraoxonase-1 Gene Expression by Resveratrol

  2004cited by this paper
• Corrigendum: Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

  2004cited by this paper
• Pharmacogenetics of paraoxonases: a brief review

  2004cited by this paper
• Association of paraoxonase 1 gene polymorphisms with risk of Parkinson′s disease: a meta-analysis

  2004cited by this paper
• Dietary Polyphenols Increase Paraoxonase 1 Gene Expression by an Aryl Hydrocarbon Receptor-Dependent Mechanism

  2004cited by this paper
• The ENCODE (ENCyclopedia Of DNA Elements) Project

  2004cited by this paper
• Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

  2004cited by this paper
• Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells.

  2004cited by this paper
• Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.

  2004cited by this paper
• Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

  2004cited by this paper
• Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress

  2003cited by this paper
• Future Studies of Low-Activity PON1 Phenotype Subjects May Reveal How PON1 Protects Against Cardiovascular Disease

  2003cited by this paper
• Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase: A Role for Sterol Regulatory Element–Binding Protein-2

  2003cited by this paper
• Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular Disease

  2003cited by this paper
• Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans.

  2003cited by this paper
• Effects of red wine consumption on serum paraoxonase/arylesterase activities and on lipoprotein oxidizability in healthy-men.

  2003cited by this paper
• Future studies of low-activity PON1 phenotype subjects may reveal how PON1 protects against cardiovascular disease.

  2003cited by this paper
• Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1

  2003cited by this paper
• Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

  2003cited by this paper
• Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status.

  2003cited by this paper
• Paraoxonase 1 promoter and coding region polymorphisms in Parkinson’s disease

  2003cited by this paper
• Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation.

  2003cited by this paper

• Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review

  2023cites this paper
• Alelos -108C/T, L55M y Q192R de paraoxoasa 1 (pon 1) en población del eje cafetero de Colombia

  2023cites this paper
• A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine.

  2022cites this paper
• A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine

  2022cites this paper
• Human carboxylesterases and fluorescent probes to image their activity in live cells.

  2021cites this paper
• Evaluating The Activity Of Paraoxonase 1 In Myocardial Infarction

  2021cites this paper
• A critical review on human serum Paraoxonase-1 in the literature: truths and misconceptions

  2020cites this paper
• The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation.

  2019cites this paper
• Evaluation of Serum malondialdehyde concentrations and enzymatic activity of paraoxonase and arile esterase in women with a recurrent spontaneous abortion

  2019cites this paper
• Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life

  2019cites this paper
• Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes

  2018influential citation
• A role for plant science in underpinning the objective of global nutritional security?

  2018cites this paper
• Phenol-enriched olive oils modify paraoxonase-related variables: A randomized, crossover, controlled trial.

  2017influential citation
• Serum paraoxonase 1 activity and lipid metabolism parameter changes in Dachshunds with chronic mitral valve disease. Assessment of its diagnostic usefulness.

  2017cites this paper
• Paraoxonase 1 (PON1) gene polymorphism and haplotype analysis in type 2 diabetes mellitus: a case–control study in the south Iranian population

  2017cites this paper
• Beta-Thalassemia Minor and the risk of Atherosclerosis: the role of the erythrocytic oxidative stress and paraoxonase 1 levels as aggravating factors

  2017cites this paper
• Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event.

  2017cites this paper
• Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study

  2016cites this paper
• Atheroprotective targets associated with high-density lipoprotein: phospholipid transfer protein, paraoxonase-1, and their effects on cerebrovascular disease

  2016cites this paper
• Concentration of Smaller High‐Density Lipoprotein Particle (HDL‐P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA)

  2016cites this paper
• The effect of the paraoxonase 1 (PON1) T(-107)C polymorphism on serum PON1 activity in women is dependent on fatty acid intake.

  2016influential citation
• Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.

  2016cites this paper
• Molecular targeting of proteins by homocysteine: implications in familial and clinical hypercholesterolemia

  2015cites this paper
• PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity1[S]

  2015cites this paper
• Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer’s Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1

  2015cites this paper
• Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.

  2015cites this paper
• Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux

  2015cites this paper
• How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae

  2015cites this paper
• Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort.

  2015cites this paper
• Expression of microRNA-132 in patient with liver cancer and mediation of microRNA-132 on cell growth of liver cancer cell

  2015cites this paper
• Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet

  2014cites this paper
• Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants

  2014cites this paper
• HDL‐3 is a Superior Predictor of Carotid Artery Disease in a Case‐Control Cohort of 1725 Participants

  2014cites this paper
• Human Paraoxonase 1 as a Pharmacologic Agent: Limitations and Perspectives

  2014cites this paper
• Regulation of Xenobiotic Metabolism in the Liver

  2014cites this paper
• Effects of a new dietary strategy in the treatment of the metabolic syndrome:: The resmena diet

  2014influential citation
• Inflammation, infection, cancer and all that…the role of paraoxonases.

  2014cites this paper
• Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects

  2013cites this paper
• International Journal of Diabetes in Developing Countries

  2013cites this paper
• THE ROLE OF HUMAN PARAOXONASE 1 (PON-1) IN VIRAL INFECTIONS

  year unknowncites this paper